Tag: Dr. Ghassan Abou-Alfa

Eisai, Merck bag Lenvima FDA approval for unresectable HCC

pharmanewsdaily- August 18, 2018

Lenvima FDA appoval : Eisai and Merck announced that the US Food and Drug Administration (FDA) has approved their kinase inhibitor Lenvima (lenvatinib) capsules for ... Read More